MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
Zynex Total Liabilities 2011-2026 | ZYXI
Annual Total Liabilities Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.4 M | 90.8 M | 50.1 M | 59.3 M | 15.3 M | 8.62 M | 6.89 M | 4.03 M | 7.89 M | 7.77 M | 8.38 M | 12.4 M | 13.9 M | 11.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 M | 4.03 M | 27.4 M |
Quarterly Total Liabilities Zynex
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.7 M | 84.7 M | 85 M | 86.4 M | 90.3 M | 89.1 M | 93.1 M | 90.8 M | 92.8 M | 90.3 M | 46.6 M | 50.1 M | 50.2 M | - | 56.2 M | 59.3 M | 27.3 M | 26.4 M | 14.1 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 8.62 M | 8.62 M | 8.62 M | 8.62 M | 9.96 M | 9.96 M | 9.96 M | 9.96 M | 4.03 M | 4.03 M | 4.03 M | 4.03 M | 7.89 M | 7.89 M | 7.89 M | 7.89 M | 7.77 M | 7.77 M | 7.77 M | 7.77 M | 8.38 M | 8.38 M | 8.38 M | 8.38 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 93.1 M | 4.03 M | 27.9 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.21 | 4.74 % | $ 3.45 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 10.52 | 0.96 % | $ 1.42 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.26 | 8.68 % | $ 902 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 12.96 | 2.82 % | $ 1.94 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 71.04 | 1.79 % | $ 105 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 37.05 | -0.96 % | $ 1.15 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.69 | 6.31 % | $ 37.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.07 | 2.67 % | $ 152 M |  France |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
334 M | $ 64.79 | 2.06 % | $ 1.92 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
13.8 M | $ 11.32 | 2.58 % | $ 306 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.43 | 0.05 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.19 | - | $ 1.33 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
83.2 M | $ 13.62 | 1.34 % | $ 880 M | Israel |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.34 | 0.75 % | $ 21.6 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 111.04 | 0.99 % | $ 193 B | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.77 | -0.41 % | $ 350 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 269.42 | 3.13 % | $ 7.6 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 62.57 | 1.86 % | $ 3.41 B |  Britain |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.11 | 1.05 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 32.77 | -0.23 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 176.42 | 4.11 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 33.71 | 2.9 % | $ 5.02 K | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 4.37 | -1.02 % | $ 646 M | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
52 M | $ 3.74 | 1.91 % | $ 154 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.22 | 0.64 % | $ 404 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 86.6 | 2.95 % | $ 3.01 B | USA |